B7–H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors-Reference-Cited by-同舟云学术

B7–H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors

Published:2020-02 Issue:2 Volume:13 Page:365-371
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Maachani Uday B.,Tosi Umberto,Pisapia David J.,Mukherjee Sushmita,Marnell Christopher S.,Voronina Julia,Martinez Daniel,Santi Mariarita,Dahmane Nadia,Zhou Zhiping,Hawkins Cynthia,Souweidane Mark M.

Funder

Cristian Rivera Foundation

Olivia Boccuzzi Foundation

Fly a Kite Foundation

McKenna Claire Foundation

Lyonhearted Foundation

Christian Koehler Foundation

Brooke Healey Foundation

Isabella Rose Romano Foundation

Joshua's Wish

Lily LaRue Foundation

Samuel Jeffers Childhood Cancer Foundation

Ty Louis Campbell Foundation

Children's Brain Tumor Family Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors;Xu;Cancer Res,2009

2. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production;Chapoval;Nat Immunol,2001

3. Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss;Ling;Genomics,2003

4. Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapy;Picarda;Clin Cancer Res,2016

5. Characterization of mouse and human B7-H3 genes;Sun;J Immunol,2002

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional and intratumoral adoptive T-cell therapy;Immuno-Oncology and Technology;2024-12

2. CAR-based therapeutic targets in pediatric high-grade glioma;2024-08-28

3. SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors;Neuro-Oncology;2024-07-29

4. CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives;EJC Paediatric Oncology;2024-06

5. Targeting both GD2 and B7-H3 using bispecific antibody improves tumor selectivity for GD2-positive tumors;2024-05-28